Issue 84, 2019

Mitochondrial heat shock protein-guided photodynamic therapy

Abstract

Mitochondria targeting sensitizers are continuing to gain importance in photodynamic therapy (PDT). Members of the 90 kDa heat shock protein (Hsp90) family, including TRAP1 (Hsp75), are overexpressed in cancer cells and help to control the antiapoptotic protein activity. The present work introduces an Hsp90 inhibitor-mitochondria targeting indocyanine dye conjugate (IR-PU) for high PDT efficacy.

Graphical abstract: Mitochondrial heat shock protein-guided photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
19 Aug 2019
Accepted
19 Sep 2019
First published
27 Sep 2019

Chem. Commun., 2019,55, 12631-12634

Mitochondrial heat shock protein-guided photodynamic therapy

A. P. Thomas, A. Lee, L. Palanikumar, B. Jana, K. Kim, S. Kim, H. Ok, J. Seol, D. Kim, B. H. Kang and J. Ryu, Chem. Commun., 2019, 55, 12631 DOI: 10.1039/C9CC06411G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements